Found: 4
Select item for more details and to access through your institution.
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 4, p. 596, doi. 10.1002/ijc.21264
- By:
- Publication type:
- Article
A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 6, p. 755, doi. 10.1002/(SICI)1097-0215(19991210)83:6<755::AID-IJC10>3.0.CO;2-S
- By:
- Publication type:
- Article
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
- Published in:
- European Journal of Immunology, 1996, v. 26, n. 1, p. 224, doi. 10.1002/eji.1830260135
- By:
- Publication type:
- Article
Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
- Published in:
- European Journal of Immunology, 1995, v. 25, n. 3, p. 664, doi. 10.1002/eji.1830250306
- By:
- Publication type:
- Article